However, it should be noted that these genetic approaches are particularly relevant in understanding rare genetic conditions associated with MASLD, such as variants in PNPLA3, TM6SF2 or HSD17B13, which have been shown to influence disease severity. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.